申请人:Eisai R&D Management Co., Ltd.
公开号:US08288538B2
公开(公告)日:2012-10-16
A compound represented by the following formula, or a salt thereof or a hydrate of the foregoing, has excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity, and cancer metastasis inhibitory activity.
R1 represents a 3- to 10-membered non-aromatic heterocyclic group or the like; R2 and R3 represent hydrogen; R4, R5, R6, and R7 may be the same or different and each represents hydrogen, halogen, C1-6 alkyl or the like; R8 represents hydrogen or the like; R9 represents a 3- to 10-membered non-aromatic heterocyclic group or the like; n represents an integer of 1 or 2; X represents —CH═, nitrogen or the like.
以下化合物,其盐或水合物,具有优异的肝细胞生长因子受体(HGFR)抑制活性,并表现出抗肿瘤活性、抑制血管生成活性和癌症转移抑制活性。其中,R1代表3-10个成员的非芳香杂环基团或类似物;R2和R3代表氢;R4,R5,R6和R7可以相同也可以不同,每个代表氢,卤素,C1-6烷基或类似物;R8代表氢或类似物;R9代表3-10个成员的非芳香杂环基团或类似物;n代表1或2的整数;X代表-CH═,氮或类似物。